DEXCOM INC — Director's Dealing 2013

Nov 6, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2013-11-04

Reporting Person: ALTMAN STEVEN R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-04	Common Stock	A	762.0	$0.0010	Acquired	5762	Direct
2013-11-04	Common Stock	A	10708.0	$0.0010	Acquired	16470	Direct

Footnotes

F1: Share units are restricted and subject to vesting in one installment on May 31, 2014. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.

F2: Share units are restricted and subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.